Skip to main content
Premium Trial:

Request an Annual Quote

IP Watch: Mayo Clinic, Life Tech, Penn State, DNA Logix, Roche, others Win US Patents

Premium

Mayo Foundation for Medical Education and Research has been awarded US Patent No. 8,673,555, "Detecting neoplasm."

William Taylor, Jonathan Harrington, Patrick Quint, Hongzhi Zou, Harold Bergen III, David Smith, and David Ahlquist are named as inventors.


Life Technologies has been awarded US Patent No. 8,673,560, "Methods and compositions for multiplex PCR."

John Leamon, Mark Andersen, and Michael Thornton are named as inventors.


The Penn State Research Foundation has been awarded US Patent No. 8,673,561, "Methods for nucleic acid manipulation."

Stephen Benkovic and Frank Salinas are named as inventors.


Bio-Dixam has been awarded US Patent No. 8,673,563, "Amplification method of methylated or unmethylated nucleic acid."

Takeshi Nagasaka, Nagahide Matsubara, Hiromi Sasamoto, and Noriaki Tanaka are named as inventors.


National Jewish Health has been awarded US Patent No. 8,673,565, "Methods and compositions for risk prediction, diagnosis, prognosis, and treatment of pulmonary disorders."

David Schwartz and Max Seibold are named as inventors.


Canadian Blood Services has been awarded US Patent No. 8,673,566, "Method for detection of Staphylococcus epidermidis."

Sandra Ramirez-Arcos and Cherie Cameron are named as inventors.


Atila Biosystems has been awarded US Patent No. 8,673,567, "Method and kit for nucleic acid sequence detection."

Youxiang Wang and Wenjing Tao are named as inventors.


Institut Pasteur has been awarded US Patent No. 8,673,568, "Molecular typing and subtyping of Salmonella by identification of the variable nucleotide sequences of the CRISPR loci."

Francois-Xavier Weill, Laetitia Fabre, Veronique Guibert, Laure Diancourt, and Sylvain Brisse are named as inventors.


DNA Logix has been awarded US Patent No. 8,673,569, "Primers for nucleic acid extension or amplification reactions."

Brent Satterfield is named as the inventor.


Genetag Technology has been awarded US Patent No. 8,673,570, "System and methods to quantify and amplify both signaling and probes for cDNA chips and gene expression microarrays."

David Shafer is named as the inventor.


Sequenom has been awarded US Patent No. 8,673,571, "Method for accurate assessment of DNA quality after bisulfite treatment."

Mathias Ehrich is named as the inventor.


Toshiba has been awarded US Patent No. 8,673,595, "Sample analysis method and assay kit used therein."

Naoko Nakamura, Koji Hashimoto, and Nobuhiro Gemma are named as inventors.


Life Technologies has been awarded US Patent No. 8,673,627, "Apparatus and methods for performing electrochemical reactions."

John Nobile, Thomas Roth, Todd Rearick, Jonathan Schultz, Jonathan Rothberg, and David Marran are named as inventors.


ETH Zurich has been awarded US Patent No. 8,673,824, "Encoded self-assembling chemical libraries (ESACHEL)."

Dario Neri and Samu Melkko are named as inventors.


Roche has been awarded US Patent No. 8,674,080, "Dye composition for liquid transfer control."

Dieter Heindl, Waltraud Ankenbauer, Hans-Peter Josel, and Christian Weilke are named as inventors.


Biosearch Technologies has been awarded US Patent No. 8,674,094, "Stabilized nucleic acid dark quencher-fluorophore probes."

Ronald Cook and Matt Lyttle are named as inventors.


Applied Biosystems (Life Technologies) has been awarded US Patent No. 8,676,383, "Device for carrying out chemical or biological reactions."

Lim Tan, Jew Ngui, Hon Shin, Ui Soh, Yang Kee, Hock Khoo, Mark Reed, Ching Lau, and Wolfgang Heimberg are named as inventors.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.